GRETCHEN DRAKE: Open Payments
NPI 1114303773 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,106 in 96 payments from 39 companies in 2025. Trend: 2023 $1,763 · 2024 $1,842 · 2025 $3,106
Food & beverage: $2,380Consulting: $726
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 11 | $1,080 |
| Merck Sharp & Dohme LLC | 6 | $241 |
| Regeneron Healthcare Solutions, Inc. | 7 | $214 |
| Novartis Pharmaceuticals Corporation | 6 | $168 |
| AstraZeneca Pharmaceuticals LP | 5 | $116 |
| Janssen Biotech, Inc. | 6 | $114 |
| Celgene Corporation | 6 | $105 |
| Exelixis Inc. | 5 | $103 |
| SpringWorks Therapeutics, Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
Products named: Enhertu, LIBTAYO, KISQALI, WELIREG, CABOMETYX, KEYTRUDA, AYVAKIT, DATROWAY.
Industry payments across TN — which companies pay providers there.
